Boulder-based biotech firm raises $620,000 in debt offering
BOULDER — MBio Diagnostics Inc., a Boulder-based biotech company that does rapid on-site sample testing, has raised $620,000 in capital.
MBio is raising funds through a debt offering and option to acquire other securities, according to a Form D filed with the U.S. Securities and Exchange Commission on May 21. The date of first sale was in December last year. MBio did not respond to a request for more information.
MBio is looking to provide rapid testing with technology that goes beyond the traditional paper test (such as what at-home pregnancy tests do today), according to the company’s website. The company has created its “lightdeck technology,” which uses fluorescence illumination and imaging for its tests.
SPONSORED CONTENT
Empowering communities
Rocky Mountain Health Plans (RMHP), part of the UnitedHealthcare family, has pledged its commitment to uplift these communities through substantial investments in organizations addressing the distinct needs of our communities.
BOULDER — MBio Diagnostics Inc., a Boulder-based biotech company that does rapid on-site sample testing, has raised $620,000 in capital.
MBio is raising funds through a debt offering and option to acquire other securities, according to a Form D filed with the U.S. Securities and Exchange Commission on May 21. The date of first sale was in December last year. MBio did not respond to a request for more information.
MBio is looking to provide rapid testing with technology that goes beyond the traditional paper test (such as what at-home pregnancy tests do today),
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
